Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Young

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Forschende Komplementarmedizin Und Klassische Naturheilkunde = Research in Complementary and Natural Classical Medicine|January 5, 2006
Patients' expectations about the benefit of antibiotic treatment: lessons from a randomised controlled trialJim Young, Christa Hugenschmidt, Antje Welge-Lüssen, et al.
Biometrics|July 28, 2016
Dynamic models for estimating the effect of HAART on CD4 in observational studies: Application to the Aquitaine Cohort and the Swiss HIV Cohort StudyMélanie Prague, Daniel Commenges, Jon Michael Gran, et al.
Antiviral Therapy|April 24, 2026
It's about time: The association between abacavir and cardiovascular diseaseJim Young, Patrick R Lawler, Erica E M Moodie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2015
Incomplete Modeling of the Effect of Antiretroviral Therapy on the Risk of Cardiovascular EventsJim Young, Erica E M Moodie, Michal Abrahamowicz, et al.
CMAJ Open|August 1, 2014
Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort studyJim Young, Martin Potter, Joseph Cox, et al.
BMC Family Practice|August 19, 2005
Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]Matthias Briel, Mirjam Christ-Crain, Jim Young, et al.
The Journal of Infectious Diseases|October 17, 2024
Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C CoinfectionEsther Truscello, Shouao Wang, Jim Young, et al.
Open Forum Infectious Diseases|March 19, 2019
Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV-Coinfected Patients in Clinical CareCarmine Rossi, Jim Young, Valérie Martel-Laferrière, et al.
International Journal of Molecular Sciences|March 25, 2015
Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individualsNasheed Moqueet, Claire Infante-Rivard, Robert W Platt, et al.
Plos Medicine|February 27, 2010
Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studiesMarcel Wolbers, Abdel Babiker, Caroline Sabin, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Forschende Komplementarmedizin Und Klassische Naturheilkunde = Research in Complementary and Natural Classical Medicine|January 5, 2006
Patients' expectations about the benefit of antibiotic treatment: lessons from a randomised controlled trialJim Young, Christa Hugenschmidt, Antje Welge-Lüssen, et al.
Biometrics|July 28, 2016
Dynamic models for estimating the effect of HAART on CD4 in observational studies: Application to the Aquitaine Cohort and the Swiss HIV Cohort StudyMélanie Prague, Daniel Commenges, Jon Michael Gran, et al.
Antiviral Therapy|April 24, 2026
It's about time: The association between abacavir and cardiovascular diseaseJim Young, Patrick R Lawler, Erica E M Moodie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2015
Incomplete Modeling of the Effect of Antiretroviral Therapy on the Risk of Cardiovascular EventsJim Young, Erica E M Moodie, Michal Abrahamowicz, et al.
CMAJ Open|August 1, 2014
Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort studyJim Young, Martin Potter, Joseph Cox, et al.
BMC Family Practice|August 19, 2005
Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]Matthias Briel, Mirjam Christ-Crain, Jim Young, et al.
The Journal of Infectious Diseases|October 17, 2024
Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C CoinfectionEsther Truscello, Shouao Wang, Jim Young, et al.
Open Forum Infectious Diseases|March 19, 2019
Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV-Coinfected Patients in Clinical CareCarmine Rossi, Jim Young, Valérie Martel-Laferrière, et al.
International Journal of Molecular Sciences|March 25, 2015
Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individualsNasheed Moqueet, Claire Infante-Rivard, Robert W Platt, et al.
Plos Medicine|February 27, 2010
Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studiesMarcel Wolbers, Abdel Babiker, Caroline Sabin, et al.
Pageof 8